Truist Financial Keeps Their Buy Rating on Intellia Therapeutics (NTLA)
Truist Financial analyst Joon Lee maintained a Buy rating on Intellia Therapeutics (NTLA – Research Report) yesterday and set a price target of $33.00. The company's shares closed yesterday at $8.55.
Protect Your Portfolio Against Market Uncertainty
Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
According to TipRanks, Lee is a 5-star analyst with an average return of 16.3% and a 43.42% success rate. Lee covers the Healthcare sector, focusing on stocks such as Corcept Therapeutics, Axsome Therapeutics, and Wave Life Sciences.
In addition to Truist Financial, Intellia Therapeutics also received a Buy from Wells Fargo's Yanan Zhu in a report issued on May 11. However, on May 8, J.P. Morgan maintained a Hold rating on Intellia Therapeutics (NASDAQ: NTLA).
Based on Intellia Therapeutics' latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $12.87 million and a GAAP net loss of $128.9 million. In comparison, last year the company had a GAAP net loss of $132.16 million
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
37 minutes ago
- Yahoo
Nvidia Stock (NVDA) Preserves Pack Leader Status Following Q1
Nvidia (NVDA) once again proved to the markets, after reporting its Q1 earnings, that it remains the undisputed leader powering the global AI revolution, driven by relentless demand for its chips, even amid ongoing geopolitical and trade headwinds. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Beyond beating all key metrics (excluding one-off events) and offering guidance that resonated well with investors, Nvidia stock experienced a strong post-earnings surge, even if the momentum cooled slightly in the days that followed. That said, there's arguably still a missing spark needed to fully reignite the stock's momentum heading into 2025. However, considering the broader growth story, Nvidia continues to trade at a very attractive valuation—one that could deliver meaningful alpha over the long term. Short- to mid-term bumps, especially tied to macro risks in China, are worth monitoring but don't alter the core thesis. Given the company's strong execution and still-intact fundamentals, I continue to rate NVDA as a Buy. As I pointed out in a previous article, for Nvidia stock to perform well after its Q1 Fiscal 2026 results, it wouldn't be enough to simply beat estimates—it needed to crush them and deliver guidance that topped market expectations. And that's precisely what Nvidia did. The company reported revenue of $44 billion (as shown in the chart below), beating its own guidance of $43 billion—a massive 69% increase year-over-year. Gross margins, which had been a point of concern during the early stages of Blackwell's rollout, came in at 71.3% (excluding the H20 charge, a financial write-off tied to its China-specific H20 GPUs). That's also above the guided range of 70.6% to 71%. Even more impressive was the Q2 guidance. Nvidia is projecting $45 billion in revenue, with a margin of plus or minus 2%. At the high end, that's $45.9 billion—above the ~$45.5 billion consensus estimate leading into earnings day. Margins are expected to rise again, landing between 71.8% and 72.0%, with a margin of error of approximately 50 basis points. At the top of that range, it suggests another round of margin expansion, which is exactly what investors wanted to hear. The company continues to state that once Blackwell production is fully ramped, margins could move into the 70–80% range over the next few quarters. This stronger-than-expected performance, along with the recovery in margins, led to long-term EPS estimates getting bumped up by around 9% starting in FY2029. Revenue projections for those years were also revised higher by roughly 8%. Not surprisingly, Nvidia shares jumped more than 5% in after-hours trading following the earnings release, although the stock mostly leveled off in the sessions since. In my view, the muted post-earnings reaction is actually a positive sign—it shows the market didn't see enough red flags to justify a selloff in Nvidia stock. However, bears argue that even with revenue jumping nearly 70% year-over-year, signs of fatigue in the growth story are evident, with sequential growth of just 12% potentially indicating that Nvidia's explosive momentum is entering a more seasonal or plateauing phase. For a company priced for hypergrowth, this kind of quarter-over-quarter slowdown can be an early warning signal. And it's not just about the numbers—geopolitical and regulatory pressures are starting to have real consequences. The U.S. export restrictions on AI chips like the H20 led to a $4.5 billion write-down and forced Nvidia to walk away from an estimated $15 billion in potential sales to China. That's not just a short-term financial hit—it also opens the door for competitors like Huawei to gain ground, especially as they accelerate domestic chip development. Although analysts have raised long-term estimates following Q1, there remains a genuine possibility that Nvidia's global dominance could face challenges over time, particularly if policy pressures persist. When factoring in the impact of the H20 write-off, Q1 would have been the first quarter since the AI boom began in which Nvidia did not achieve sequential growth. And for a stock valued for perfection, even a modest slowdown can pose a valuation risk. To me, the bigger issue here is that this goes beyond Nvidia—it's about the strategic direction of U.S. tech leadership. As CEO, Jensen Huang has warned that if the U.S. continues down this restrictive path without a more balanced strategy, it may ultimately strengthen Huawei and erode America's edge in AI. That's the kind of long-term headwind that bears are likely to latch onto as the growth narrative gets more complicated. But setting the macro risks aside, Nvidia's bull case remains intact after Q1, especially when considering its growth. The company continues to stand out as a GARP (growth at a reasonable price) opportunity. Currently, Nvidia trades at 31.6x forward earnings, with a consensus growth rate of 29% CAGR over the next three to five years. This results in a PEG ratio of just 1x—virtually identical to Advanced Micro Devices (AMD), despite AMD's significantly slower growth outlook, and significantly lower than most of the other Magnificent 7 names. Of course, for that valuation to hold up, Nvidia's growth trajectory needs to remain clean and strong. But honestly, it's hard to think of another company with Nvidia's size and scale, this level of fundamental quality, and such massive exposure to secular tailwinds like AI, trading at such an attractive growth-adjusted valuation. Among the 40 analysts who've covered NVDA in the past three months, there's hardly any room for doubt: 35 rate the stock as a Buy, while only four suggest Hold. Not a single analyst rates NVDA stock as a Sell. Currently, NVDA's average stock price target is $173.57, implying a potential upside of 22% from the current share price. Setting aside one-off events, Nvidia left the bears with almost nothing to complain about—crushing its own guidance and delivering a Q2 forecast that dispels doubts about how quickly gross margins are recovering. While risks like evolving U.S. sanctions on China, Nvidia's ability to maintain its presence in that market, and rising local competition are worth keeping an eye on, they don't outweigh the current risk-reward of going long, especially given the company's strong growth trajectory. Disclaimer & DisclosureReport an Issue Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
CNBC
39 minutes ago
- CNBC
Thawing of IPO market is good news for Goldman Sachs, car stocks catch a break
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Market update: The major averages are off their highs of the day, but holding on to early morning gains made on the back of a stronger-than-expected May nonfarm payrolls report. As discussed during the meeting , we need to be conscious of the real risks out there — like a resurgence of inflation on the back of tariffs or a need for job cuts in the auto sector due to a lack rare earth metals needed to manufacture vehicles — but it's hard to get too negative on the overall market so long as the U.S. consumer remains employed. Ultimately, there is still a lot to like about the stock market for those ready and willing to the research and focus on the fundamentals. Shares of Lululemon are under significant pressure Friday after the apparel retailer reported a better-than-expected quarter but cut its outlook for the full year due to the "dynamic macroenvironment." The news is just the latest reminder that while the economy is holding in thanks to low unemployment, consumers still feel the pressure of high prices and may look to alter shopping activity. In this case, the news bodes well for shares of Club holding TJX Companies , which provides some of the best value around when it comes to apparel and home goods. Automaker stocks are getting some relief Friday following a report from Reuters that China granted temporary export licenses to suppliers of the big three U.S. automakers ( Ford , General Motors , and Stellantis ) for rare earth materials. More IPO news: Crypto exchange Gemini unveiled plans to go public in a new confidential filing with the Securities and Exchange Commission on Friday. This comes one day after stablecoin issuer Circle 's IPO, which saw the stock advance roughly 168%. Prior to that, CoreWeave started trading on the Nasdaq in late March in the biggest venture-backed tech IPO since 2021. Next week, fintech firm Chime will debut on the exchange as well. All of this action is a good indicator that more companies will go public, according to Jim Cramer. That's great news for Club holding Goldman Sachs' crucial investment banking business. The Wall Street bank derives revenues from facilitating these kinds of deals as an underwriter or through advisory fees. It also signals a potential rebound for a key division in Goldman. M & A and IPO activity has been lackluster in recent years as macroeconomic uncertainty and the regulatory environment has kept companies on the sidelines and more conservative with capital. "After we figure out tariffs, it's going to be mergers. It's very hard to do it right now, but I think Goldman Sachs is very attractive right here," Jim said Friday. Next week: We've got Apple's WWDC event kicking off Monday, where investors will look for any signs of progress with the company's AI strategy. We've also got Nvidia's GTC event in Paris starting on Tuesday. Tesla is expected to launch it's robotaxi service in Austin, Texas, in the back half of the week. On the economic front, we'll get an update on inflation with the May consumer price index out Wednesday. (See here for a full list of the stocks in Jim Cramer's Charitable Trust.) As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio. If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB. NO SPECIFIC OUTCOME OR PROFIT IS GUARANTEED.
Yahoo
43 minutes ago
- Yahoo
Why Pony AI Inc. (PONY) Crashed On Wednesday
We recently published a list of . In this article, we are going to take a look at where Pony AI Inc. (NASDAQ:PONY) stands against other worst-performing stocks on Wednesday. Pony AI Inc. (NASDAQ:PONY) dropped its share prices by 5.06 percent to finish at $13.14 apiece as investors disposed of shares amid the risks of the faltering US-China trade talks and renewed calls from other states to delist Chinese firms from the stock exchanges. Following the two countries' 90-day tariff truce, US President Donald Trump expressed his frustration with China on Wednesday, saying that Chinese President Xi Jinping is 'very tough and extremely hard to make a deal with.' A close-up of a digital cloud, signifying the expansive reach of the software-as-a-service solution. Trump's social media post casted doubts over an expected potential phone call between the two leaders this week, with fears spilling over to stocks of Chinese companies, including Pony AI Inc. (NASDAQ:PONY). Further triggering concerns were mounting calls from US states' comptrollers to delist Chinese companies. In a newly issued statement, Indiana Comptroller Elise Nieshalla said that there is a growing risk posed by China-based companies due to widespread failures to meet US transparency, accounting, and standards. 'As stewards of invested public funds, we have a responsibility to protect our beneficiaries from foreign entities to seek to exploit our capital markets while evading accountability,' she said. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
